Donors such as Bill & Melinda Gates Foundation, USAID and Global Affairs Canada are supporting the TB REACH Wave 6 initiative to fund innovation and research to (i) improve detection, linkage to treatment and reporting of TB, and (ii) improve TB treatment adherence and outcomes. The Arcady Group founder, Bruce Thomas, helped launch the Wave 6 call, presenting an overview of the TB adherence technologies and highlighting areas of interest and focus for Wave 6 applicants.
The presentation concluded with the following recommendations for country programs interested in gaining experience with, and insights about, the acceptability and impact of adherence technologies:
- Proposals utilizing and evaluating adherence technologies and technology-enhanced patient management are invited/encouraged.
- Although 99DOTS, V-DOT, and evriMED are of particular interest, proposals involving other technologies/approaches also are invited.
- It is desirable to have work done in, and have strong involvement from, high burden country programs.
To find out more: https://lnkd.in/dAb24R7.